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Fluorescence anisotropyA number of recently solved crystal structures of G-protein coupled receptors reveal the presence of closely
associated cholesterol molecules in the receptor structure. We have previously shown the requirement of
membrane cholesterol in the organization, dynamics and function of the serotonin1A receptor, a representative
G‐protein coupled receptor. In this work, we explored the role of membrane cholesterol in the stability of the
human serotonin1A receptor. Analysis of sensitivity of the receptor to thermal deactivation, pH, and proteolytic
digestion in control, cholesterol-depleted and cholesterol-enriched membranes comprehensively demonstrate
thatmembrane cholesterol stabilizes the serotonin1A receptor.We conclude that these results could have poten-
tial implications in future efforts toward crystallizing the receptor.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Cholesterol represents the most abundant and important component
of eukaryotic membranes and plays a crucial role inmembrane organiza-
tion, dynamics, function and sorting [1,2]. Cholesterol is the end product
of a long, multi-step and exceedingly ﬁne-tuned sterol biosynthetic
pathway involving more than 20 enzymes. According to the “Bloch
hypothesis”, proposed by Konrad Bloch, the sterol biosynthetic path-
way parallels sterol evolution [3]. It essentially means that cholester-
ol is selected over a very long time scale of natural evolution for its
ability to optimize certain physical properties of eukaryotic cell mem-
branes with regard to biological functions.
In biological and model membranes, cholesterol is often found
distributed non-randomly (thereby resulting in variable patchiness
of the membrane) in domains [4–7]. These types of domains (some-
times termed as ‘lipid rafts’) are believed to be important in cellular
physiology since membrane sorting and trafﬁcking [8], signal trans-
duction processes [9], and the entry of pathogens [10,11] have been
attributed to these type of domains. Importantly, cholesterol has
been shown to play a crucial role in the function and organization
of membrane proteins and receptors [12–15]. The exact mechanism
of the interaction of cholesterol withmembrane proteins and receptorsine-1A receptor; 8-OH-DPAT,
nic acid; BSA, bovine serum al-
id; CCM, cholesterol consensus
ino acid consensus; DMPC,
henyl-1,3,5-hexatriene; GPCR,
n; PMSF, phenylmethylsulfonyl
: +91 40 2716 0311.
).
l rights reserved.is not clear. It has been proposed that such effects of cholesterol on
integral membrane proteins could occur either through speciﬁc molec-
ular interaction, or due to alterations in membrane physical properties,
or by a combination of both [16,17].
The G-protein coupled receptor (GPCR) superfamily is the largest
and most diverse protein family in mammals, involved in signal
transduction across membranes [18,19]. GPCRs are typically seven
transmembrane domain proteins and include >800 members which
are encoded by ~5% of human genes [20]. Since GPCRs regulate mul-
tiple physiological processes, they have emerged as major targets for
the development of novel drug candidates in all clinical areas [21].
It is estimated that ~50% of clinically prescribed drugs act as either
agonists or antagonists of GPCRs [22]. The serotonin1A receptor is an
important neurotransmitter receptor of the GPCR family and is impli-
cated in the generation andmodulation of various cognitive, behavioral
and developmental functions [23–25]. Serotonin1A receptor agonists
[26] and antagonists [27] represent major classes of molecules with
potential therapeutic applications in anxiety- or stress-related disorders.
Previous work from our laboratory comprehensively demonstrated
the requirement of membrane cholesterol in the organization, dynam-
ics and function of the serotonin1A receptor ([28–31]; reviewed in refs.
[13,14]). We also showed that the interaction between cholesterol and
the serotonin1A receptor is considerably stringent since immediate bio-
synthetic precursors of cholesterol (differing with cholesterol in a double
bond)werenot able tomaintain receptor function [29,32,33]. An interest-
ing feature fromanumber of recently solved crystal structures of GPCRs is
the close association of cholesterol in the receptor structure. For example,
high resolution crystal structures of GPCRs such as rhodopsin [34], the
β1-adrenergic receptor [35], and β2-adrenergic receptor [36,37] all show
closely associated cholesterol molecules. In this context, we recently pro-
posed that cholesterol binding sites in GPCRs could represent
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protein interfaces [38]. Interestingly, cholesterol has been previously
reported to improve stability of the β2-adrenergic receptor [39], and
appears to be necessary for crystallization of the receptor [36]. The
cholesterol analogue, cholesterol hemisuccinate, has been shown
to stabilize the β2-adrenergic receptor against thermal inactivation
[37]. Although cholesterol sensitivity of the serotonin1A receptor
constituted one of the early reports in the area of GPCR-cholesterol
interaction [28], the effect of membrane cholesterol on the stability
of the receptor has not been explored yet. In the present work, we
have studied the role of membrane cholesterol in the stability of
the human serotonin1A receptor. For this, we monitored the ligand
binding function of the receptor inmembranes of varying cholesterol
content under conditions such as high temperature, extreme pH
and proteolytic degradation that could affect receptor stability. Our
results show that membrane cholesterol stabilizes ligand binding
of the serotonin1A receptor. These results could provide useful insight
into future efforts to crystallize the receptor.
2. Materials and methods
2.1. Materials
BCA, cholesterol, DPH, DMPC, EDTA, EGTA, MβCD, MgCl2, MnCl2,
Na2HPO4, PMSF, penicillin, streptomycin, gentamycin sulfate, serotonin,
polyethylenimine, trypsin, acetic acid, CAPS and Tris were obtained
from Sigma Chemical Co. (St. Louis, MO). Trypsin inhibitor was from
Roche Applied Science (Indianapolis, IN). DMEM/F-12 (Dulbecco's
modiﬁed Eagle's medium), fetal calf serum, and geneticin (G 418)
were from Invitrogen Life Technologies (Carlsbad, CA). Amplex Red
cholesterol assay kit was from Molecular Probes (Eugene, OR). BCA
reagent for protein estimation was from Pierce (Rockford, IL). [3H]
8-OH-DPAT (sp. activity 106 Ci/mmol) was purchased from DuPont
New England Nuclear (Boston, MA). GF/B glass microﬁber ﬁlters were
from Whatman International (Kent, U.K.). All other chemicals used
were of the highest purity available. Water was puriﬁed through a
Millipore (Bedford, MA) Milli-Q system and used throughout.
2.2. Methods
2.2.1. Cells and cell culture
Chinese Hamster Ovary (CHO) cells stably expressing the human
serotonin1A receptor (termed as CHO-5-HT1AR) were maintained in
D-MEM/F-12 (1:1) supplemented with 2.4 g/l of sodium bicarbonate,
10% fetal calf serum, 60 μg/ml penicillin, 50 μg/ml streptomycin,
50 μg/ml gentamycin sulfate, and 200 μg/ml geneticin in a humidiﬁed
atmosphere with 5% CO2 at 37 °C.
2.2.2. Cell membrane preparation
Cell membranes were prepared as described earlier [40]. Total
protein concentration in isolated cell membranes was determined
using the BCA assay [41].
2.2.3. Cholesterol depletion and enrichment of cell membranes
Cholesterol depletion or enrichment of cell membraneswas achieved
by utilizing either MβCD or cholesterol-MβCD complex [30]. The water
soluble cholesterol-MβCD complex was prepared as described previous-
ly [28]. Brieﬂy, the required amounts of cholesterol and MβCD in a ratio
of 1:10 (mol/mol) were dissolved in 50 mM Tris, pH 7.4 buffer
under constant shaking at 25 °C. Stock solutions (typically 4 mM
cholesterol:40 mM MβCD) of this complex were freshly prepared
prior to each experiment. In order to achieve cholesterol depletion
or enrichment, membranes suspended at a protein concentration of
2 mg/ml were treated with either 30 mM MβCD or cholesterol-
MβCD (1 mM:10 mM) complex in 50 mM Tris, pH 7.4 buffer at
25 °C under constant shaking for 30 min. Membranes were thenspun down at 50,000 ×g for 10 min, washed once with 50 mM Tris,
pH 7.4 buffer and resuspended in the same buffer.
2.2.4. Incubation of cell membranes at high temperature
Control, cholesterol-depleted and -enriched membranes at a pro-
tein concentration of 2 mg/ml were incubated at 37 °C for varying
time periods ranging from 0 to 2 h. After incubation, membranes
were cooled to 25 °C and radioligand binding assays were carried out.
2.2.5. Incubation of cell membranes at varying pH
Control, cholesterol-depleted and -enriched membranes suspended
in 50 mM Tris, pH 7.4 buffer were spun down at 50,000 ×g for 10 min,
resuspended in buffers spanning a pH range 4–12 at a protein concen-
tration of 2 mg/ml and incubated at 25 °C for 30 min. The buffers
used were 10 mM acetate (pH 4 and 6), 50 mM Tris (pH 8), 10 mM
CAPS (pH 10) and 50 mM CAPS (pH 12). After incubation, membranes
were spun down at 50,000 ×g for 10 min, washed once with 50 mM
Tris, pH 7.4 buffer and resuspended in the same buffer for neutraliza-
tion. Neutralized membranes were utilized to perform radioligand
binding assays.
2.2.6. Trypsin treatment of cell membranes
Proteolytic degradation of the serotonin1A receptor in membranes
was achieved utilizing trypsin. Trypsin and trypsin inhibitor stock solu-
tions were prepared in 50 mM Tris, pH 7.4 buffer. Control, cholesterol-
depleted and -enriched membranes at a protein concentration of 2 mg/
ml were incubated with 0.05 mg/ml (0.33 U/ml) trypsin for 15 min at
25 °C. Trypsin action was terminated after incubation by adding
0.1 mg/ml trypsin inhibitor and radioligand binding assays were car-
ried out immediately.
2.2.7. Radioligand binding assays
Receptor binding assays in control and cholesterol-depleted and
-enriched membranes were carried out as described earlier [29,30,42]
with ~40 μg total protein. The concentration of [3H]8-OH-DPAT used
was 0.29 nM.
2.2.8. Estimation of cholesterol and phospholipid contents
Cholesterol content in cell membranes was estimated using the
Amplex Red cholesterol assay kit [43]. The content of lipid phosphate
in membranes was determined subsequent to total digestion with
perchloric acid [44] using Na2HPO4 as standard. DMPC was used as an
internal standard to assess lipid digestion. Samples without perchloric
acid digestion produced negligible readings.
2.2.9. Fluorescence anisotropy measurements
Fluorescence anisotropy experiments were carried out using the
ﬂuorescent probe DPH as described previously [29,45]. Steady state
ﬂuorescence was measured in a Hitachi F-4010 spectroﬂuorometer
using 1 cm path length quartz cuvettes at room temperature (~23 °C).
Excitation and emission wavelengths were set at 358 and 430 nm.
Excitation and emission slits with nominal bandpasses of 1.5 and
20 nm were used. The optical density of the samples measured at
358 nm was ~0.12. Fluorescence anisotropy measurements were
performed using a Hitachi polarization accessory. Anisotropy (r)
values were calculated from the equation [46]:
r ¼ IVV−GIVH
IVV þ 2GIVH
where IVV and IVH are the measured ﬂuorescence intensities (after
appropriate background subtraction) with the excitation polarizer
vertically oriented and the emission polarizer vertically and horizon-
tally oriented, respectively. G is the grating correction factor and is
the ratio of the efﬁciencies of the detection system for vertically
and horizontally polarized light and is equal to IHV/IHH. All experiments
Fig. 1. Lipid contents of membranes isolated from CHO-5-HT1AR cells upon cholesterol
depletion and enrichment. Panel A shows cholesterol (hatched bar) and phospholipid
contents (crisscrossed bar) in cholesterol-depleted (MβCD treated) and -enriched
(cholesterol–MβCD complex treated) membranes. Values are expressed as percent-
ages of respective lipid contents in control (untreated) membranes. Panel B represents
the molar ratio of cholesterol and phospholipid contents in cholesterol-depleted and
-enriched membranes. Data represent means±S.E. of ﬁve independent experiments.
See Materials and methods for more details.
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cence anisotropy are shown in Fig. 5.
2.2.10. Statistical analysis
Signiﬁcance levels were estimated using Student's two-tailed un-
paired t-test using Graphpad Prism software version 4.0 (San Diego, CA).
3. Results and discussion
3.1. Lipid contents of cell membranes treated with either MβCD or cho-
lesterol–MβCD complex
MβCD is a water-soluble polymer with a nonpolar central cavity. It
has previously been shown to selectively and efﬁciently extract choles-
terol from cellular membranes by incorporating it in a central nonpolar
cavity [47]. Lipid contents of isolated cell membranes upon cholesterol
depletion and enrichment are shown in Fig. 1. Treatment of cell mem-
branes with MβCD alone resulted in reduction in cholesterol content,
while treatment with cholesterol-MβCD complex resulted in an increase
in cholesterol content (see Fig. 1A). Cholesterol content was reduced to
~18% of control (untreated) membranes upon treatment with MβCD.
On the other hand, membranes treated with cholesterol-MβCD complex
exhibited ~53% enrichment in cholesterol content, relative to control
membranes. Importantly, phospholipid contents are found to be
unaltered under these conditions (see Fig. 1A). The ratio of choles-
terol to phospholipid contents (C/PL) in membranes provides an
estimate of the fraction of cholesterol present. C/PL ratio was found
to be ~0.14 (mol/mol) for control membranes (see Fig. 1B). This ratio
is altered to ~0.03 and ~0.21 upon cholesterol depletion and enrichment
of membranes, respectively.
3.2. Effect of membrane cholesterol on temperature sensitivity of the
serotonin1A receptor
Speciﬁc [3H]8-OH-DPAT binding to serotonin1A receptors in isolated
cell membranes upon cholesterol depletion and enrichment is shown in
Fig. 2A. The ﬁgure shows that the ligand binding function of the
serotonin1A receptor is reduced by ~21% in cholesterol-depleted mem-
branes. On the other hand, cholesterol-enriched membranes exhibited
an increase of ~16% in ligand binding relative to control membranes.
In order to explore the effect of cholesterol content on the temper-
ature sensitivity (stability) of the serotonin1A receptor, we monitored
ligand binding of the receptor at 25 °C in cholesterol-depleted and
-enriched membranes, pre-treated at 37 °C for varying time periods.
Fig. 2B and C show that ligand binding exhibits a progressive reduction
with an increase in the time of pre-treatment for control and cholesterol-
depletedmembranes. The reduction in ligand binding under these condi-
tions is found to bemore in case of cholesterol-depletedmembranes and
is not signiﬁcant for cholesterol-enrichedmembranes (see Fig. 2B and C).
Fig. 2C shows that after 2 h of treatment at 37 °C, ligand binding was
reduced to ~74% and ~49% of the activity monitored in the absence of
any treatment in control and cholesterol-depleted membranes, respec-
tively. This reduction in ligand binding in these cases could be due to
irreversible thermal denaturation of either the receptor or G-proteins
during incubation at 37 °C. We have previously shown that incubation
at high temperature could cause irreversible inactivation of G-proteins
coupled to the serotonin1A receptor [48]. It should be mentioned here
that the conformation of the subtype of G-proteins that is coupled to
the serotonin1A receptor, namely Gi [49], has previously been reported
to be sensitive to temperature [50]. The reduction in ligand binding also
could be due to inactivation of the serotonin1A receptor since it is
known thatmembraneproteins could exhibit a loss of structure and func-
tion due to thermal deactivationwhen exposed to high temperature [51].
Fig. 2B and C show thatmembrane cholesterol provides considerable
protection against thermal deactivation since receptors in cholesterol-
enrichedmembranes do not show signiﬁcant reduction in ligand bindingactivity even after 2 h of treatment at 37 °C. This is also apparent from the
different extents of reduction in ligand binding for control (~26%) and
cholesterol-depleted (~51%) membranes after 2 h of treatment at 37 °C.
Membrane cholesterol therefore appears to provide stability to the recep-
tor against thermal deactivation. In other words, receptors inmembranes
with relatively high cholesterol content appear to enjoy less sensitivity to
thermal deactivation relative to receptors in amembranewith lower cho-
lesterol content. Interestingly, cholesterol has been shown to increase the
thermal stability of membrane proteins such as the Ca2+/Mg2+-ATPase
[52], the nicotinic acetylcholine receptor [53] and the oxytocin receptor
[54].3.3. Effect of membrane cholesterol on pH sensitivity of the serotonin1A
receptor
Side chains of acidic or basic amino acid residues of proteins are sen-
sitive to pH of the environment. The charge status of these pH-sensitive
residues could contribute to conformation of the protein and in turn
could govern its function. Fig. 3A depicts ligand binding activity of the
serotonin1A receptor in control membranes pre-treated at various pH.
Ligand binding activity of the receptor was drastically reduced in case
of highly acidic (pH 4) or basic (pH 12) conditions. This could be
due to pH-induced irreversible denaturation of the receptor and/or
G-protein. Such pH-dependent activity has previously been reported
for GPCRs such as the β2-adrenergic receptor [55].
Fig. 3. Effect of membrane cholesterol content on pH sensitivity of ligand binding of the
serotonin1A receptor. Panel A shows speciﬁc [3H]8-OH-DPAT binding to receptors in
control membranes pre-incubated in buffers of varying pH. Values are expressed as
percentages of speciﬁc binding obtained in membranes pre-incubated in pH 10 buffer.
Panel B shows the effect of membrane cholesterol content on pH-sensitivity of the re-
ceptor. Control, cholesterol-depleted and -enriched membranes were suspended in
buffer, spanning a pH range 4–12, and incubated at 25 °C for 30 min. Membranes
were neutralized following incubation, and [3H]8-OH-DPAT binding assays were
performed. Panel B represents speciﬁc [3H]8-OH-DPAT binding to receptors in control
(222), cholesterol-depleted (…..) and -enriched (—————) membranes, pre-incubated
in buffers of varying pH. Values are expressed as percentages of speciﬁc binding
obtained in cholesterol-enriched membranes pre-incubated in pH 10 buffer. Data
shown are means±S.E. of four independent experiments [*corresponds to signiﬁcant
(p=0.007) difference in speciﬁc [3H]8-OH-DPAT binding to receptors in membranes
pre-treated at pH 10 relative to membranes pre-treated at pH 8]. See Materials and
methods for more details.
Fig. 2. Effect of membrane cholesterol content on temperature sensitivity of ligand bind-
ing of the serotonin1A receptor. Panel A shows speciﬁc [3H]8-OH-DPAT binding to rec-
eptors in cholesterol-depleted and -enriched membranes. Values are expressed as
percentages of speciﬁc binding obtained in control membranes. Panels B and C show
the effect of cholesterol on stability of the receptor incubated at 37 °C for varying time
periods. Control, cholesterol-depleted and -enriched membranes were incubated at
37 °C for varying time periods ranging from 0 to 2 h. After incubation, membranes were
cooled to 25 °C and ligand binding was carried out. Panel B shows speciﬁc [3H]8-OH-DPAT
binding to receptors in control (222), cholesterol-depleted (…..) and -enriched (—————)
membranes, pre-incubated at 37 °C for increasing time periods. Values are expressed as per-
centages of speciﬁc binding obtained in control membranes without incubation at 37 °C.
Panel C shows speciﬁc [3H]8-OH-DPAT binding to receptors in control,
cholesterol-depleted and -enriched membranes, pre-incubated at 37 °C for 0 h (hatched
bar), 1 h (vertical bar), 1.5 h (horizontal bar) and2 h (crisscrossedbar). Values are expressed
as percentages of speciﬁc binding obtained in membranes in absence of incubation at 37 °C
for respective conditions. Data represent means±S.E. of four independent experiments [*
and # correspond to signiﬁcant (p=0.006 and 0.005, respectively) difference in speciﬁc
[3H]8-OH-DPAT binding to cholesterol-depleted and -enriched membranes relative to con-
trol membranes]. See Materials and methods for more details.
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pH-sensitivity of the serotonin1A receptor, wemonitored ligand binding
in cholesterol-depleted and -enrichedmembranes, pre-treated at varyingpH ranging from 4 to 12. The ligand binding activity of receptors inmem-
branes of different cholesterol content, pre-treated at various pH, is
shown in Fig. 3B. Interestingly, ligand binding of the receptor is found
to be correlated with the cholesterol content of the membrane at each
pH. Ligand binding was found to be maximum in cholesterol-enriched
membranes and minimum in cholesterol-depleted membranes, with
control membranes displaying ligand binding in the intermediate range
at each pH. Our results therefore show that membrane cholesterol pro-
vides stability to the receptor against pH-induced denaturation.
3.4. Effect of membrane cholesterol on proteolytic degradation of the
serotonin1A receptor
Proteases are enzymes that hydrolyze proteins and are abundantly
present in cells. We monitored the effect of cholesterol depletion
and enrichment on the proteolytic degradation of the serotonin1A
receptor in order to explore whether membrane cholesterol could
protect the receptor from proteolytic degradation. For this, ligand
binding was measured in membranes of different cholesterol levels
Fig. 4. Effect of membrane cholesterol content on proteolytic degradation of the
serotonin1A receptor. Panel A shows a schematic representation of the membrane em-
bedded human serotonin1A receptor in a membrane bilayer composed of phospho-
lipids and cholesterol, representative of eukaryotic membranes. The transmembrane
helices of the receptor were previously predicted using TMHMM2 [38]. Transmem-
brane stretches, composed of ~22 amino acids, are depicted as putative α-helices.
The amino acids in the receptor sequence are shown as circles. There are 44 sites
(shown in magenta) susceptible to cleavage by trypsin. Trypsin cleaves proteins pre-
dominantly at the carboxyl side of the amino acids lysine (K) or arginine (R) [56].
Importantly, one of the cleavage sites is present in DRY motif (highlighted as a circle)
of the receptor, crucial for G-protein coupling [57]. Further structural details of the
receptor are available in [63]. Adapted and modiﬁed from ref. [38]. Panel B shows the
effect of membrane cholesterol content on proteolytic degradation of the receptor.
Control, cholesterol-depleted and -enriched membranes were treated with trypsin at
25 °C for 15 min. The action of trypsin was terminated by adding trypsin inhibitor
and ligand binding assays were immediately carried out. Speciﬁc [3H]8-OH-DPAT bind-
ing to receptors are shown in the presence (crisscrossed bar) and absence (hatched
bar) of trypsin treatment in control, cholesterol-depleted and -enriched membranes.
Values are expressed as percentages of speciﬁc binding obtained in membranes in
absence of trypsin treatment for each condition. Values are normalized this way to
eliminate any effect due to alteration in ligand binding associated with modulation of
membrane cholesterol content. Data shown are means±S.E. of four independent
experiments (*corresponds to signiﬁcant (p=0.013) and #represents not signiﬁcant
(p=0.256) difference in speciﬁc [3H]8-OH-DPAT binding to receptors in cholesterol-
enriched and -depleted membranes relative to control membranes in each case). See
Materials and methods for more details.
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proteins predominantly at the carboxyl side of the amino acids lysine
or arginine [56]. The serotonin1A receptor contains 44 sites (including
two in putative transmembrane domains) susceptible to cleavage by
trypsin (see Fig. 4A). Importantly, one of the sites is located in the
conserved DRY motif which is known to be crucial for G-protein cou-
pling of GPCRs [23,57]. In addition, membrane anchored G-proteins
could represent one of the prime targets of trypsin as proposed earlier
[58]. We initially conﬁrmed the efﬁcacy of trypsin treatment of the
serotonin1A receptor (see Supplementary Fig. 1). The serotonin1A
receptor exhibits a decrease in ligand binding upon trypsin treatment
in both control and cholesterol-depleted membranes (see Fig. 4B).
Trypsin treatment caused ~54% and ~42% reduction in the ligand
binding activity in control and cholesterol-depleted membranes,
respectively. On the other hand, receptors in cholesterol-enriched
membranes retained ligand binding ability to a considerable extent
even after trypsin treatment. Receptors in these membranes exhibited
only ~24% reduction in ligand binding upon trypsin treatment. The
reduction in ligand binding could partly be due to loss of G-protein cou-
pling upon cleavage of either the receptor at DRY region or G-proteins
[57], since agonist binding is sensitive to the extent of G-protein cou-
pling of receptors [59]. These results indicate that receptors in cholesterol
enriched-membranes are less susceptible to proteolytic degradation
probably due to the less accessibility of the receptor to trypsin. Alterna-
tively, almost similar extent of reduction in ligand binding in both control
and cholesterol-depleted membranes points out that receptors in these
membranes are equally accessible to trypsin. It is possible that there
could be a threshold cholesterol content in cell membranes which deter-
mines the susceptibility to proteolytic degradation. Taken together, our
results highlight the protective role ofmembrane cholesterol against pro-
teolytic degradation.
3.5. Effect of membrane cholesterol on cell membrane organization and
dynamics: results from DPH anisotropy measurements
Membrane order and dynamics could be an important determinant
of receptor structure and function [12,60]. In order to gain insight into
the changes inmembrane order induced uponmodulation of cholester-
ol levels in cellmembranes,wemonitored the steady-stateﬂuorescence
anisotropy of themembrane probe, DPH. DPH, a rod-likemolecule, par-
titions into the interior of the bilayer and represents a popular mem-
brane probe for monitoring organization and dynamics in membranes
[61]. Fluorescence anisotropy is correlated to the rotational diffusion
of membrane-embedded probes [46], which is sensitive to the packing
of fatty acyl chains and cholesterol. This is due to the fact that ﬂuores-
cence anisotropy depends on the degree to which the probe is able to
reorient after excitation, and probe reorientation is a function of local
lipid packing. The change in ﬂuorescence anisotropy of DPH incorporat-
ed in cholesterol-depleted and -enrichedmembranes is shown in Fig. 5.
The ﬂuorescence anisotropy of DPH in control membranes is found
to be ~0.23. Interestingly, the ﬂuorescence anisotropy of DPH shows a
decrease of ~17% (to ~0.19) upon cholesterol depletion (see Fig. 5).
Cholesterol-enriched membranes, on the other hand, exhibit an increase
of ~13% inDPH anisotropy (to ~0.26) suggesting that DPHexperiences an
overall more ordered environment in cholesterol-enriched membranes.
The ﬂuorescence anisotropy of DPH in cell membranes appears to corre-
late well with cholesterol/phospholipid ratio of membranes with varying
cholesterol contents (see inset in Fig. 5).
Taken together, our results show that membrane cholesterol sta-
bilizes the serotonin1A receptor as evident from the sensitivity of
the receptor to thermal deactivation, pH, and proteolytic digestion.
Recent efforts in crystallizing GPCRs have shown that the addition
of cholesterol often turns out to be crucial for maintaining receptor
stability, an essential criterion for obtaining good crystals for structur-
al biological work [62]. It is important to mention in this context
that we have recently reported from receptor modeling studies thatthe serotonin1A receptor is more compact in the presence of tightly
bound cholesterol [63]. Such a compact conformation could contribute
to receptor stability. Interestingly, we have very recently identiﬁed cho-
lesterol recognition/interaction amino acid consensus (CRAC) motifs
Fig. 5. Effect of membrane cholesterol content on ﬂuorescence anisotropy of the mem-
brane probe DPH. Fluorescence anisotropy experiments were performed with control,
cholesterol-depleted and -enriched membranes containing 50 nmol phospholipid at a
probe to phospholipid ratio of 1:100 (mol/mol) at room temperature (~23 °C). Values
represent means±S.E. of duplicate points from four independent measurements
(* and # correspond to signiﬁcant (p=0.001 and 0.006, respectively) difference in
cholesterol-depleted and -enriched membranes relative to control membranes). The
inset shows a plot between ﬂuorescence anisotropy of DPH and cholesterol/phospholipid
molar ratio in membranes with varying cholesterol content. See Materials and methods
for more details.
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teristic structural feature of proteins that are believed to result in
preferential associationwith cholesterol [65,66]. In addition, in the crys-
tal structure of the β2-adrenergic receptor, a cholesterol consensus
motif (CCM) has been identiﬁed consisting of four amino acids [37].
We have previously shown that CCM is present in the serotonin1A re-
ceptor [38]. Interestingly, recent molecular dynamics simulations have
shown that membrane cholesterol speciﬁcally interacts with trans-
membrane domains of GPCRs such as rhodopsin [67] and human A2A
adenosine receptor [68], thereby stabilizing helix II of the human A2A
adenosine receptor. A consequence of this interaction is that the
receptor couples to G-proteins only in presence of cholesterol. Mem-
brane ordering induced by cholesterol (see Fig. 5) could also contrib-
ute to receptor stability.
We have used the speciﬁc binding of the agonist 8-OH-DPAT in
monitoring the stability of the serotonin1A receptor. A major reason
for the popularity of the serotonin1A receptor subtype is the early avail-
ability of this selective agonist that led to extensive biochemical, physi-
ological, and pharmacological characterization of the receptor [23].
Results obtained from point mutations have suggested that Asp82 and
Asp116 in transmembrane helices II and III are crucial for binding agonist
binding to the receptor [69]. In addition, residues such as Ser393 and
Asn396 have been shown to be crucial for agonist binding [70].
This stabilizing effect of cholesterol on membrane proteins could
be considered analogous to the well documented role of trehalose
as a stabilizer of membrane and soluble proteins [71–73]. In addition,
it has recently been shown that cholesterol stabilizes less stable dis-
coidal high density lipoproteins, apparently by facilitating favorable
packing interactions [74]. In this overall context, our results could
have potential implications in future crystallization efforts of the
serotonin1A receptor in particular, and the storage and transporta-
tion of biomaterials in general.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamem.2012.07.032.
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